Gastritis and carditis

Modern Pathology

Volumn 16, Issue 4, 2003, Pages 325-341

  Owen, David A ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Atrophic gastritis; Carditis; Gastric cardia; Gastric Crohn's disease; Gastritis; Helicobacter; Lymphocytic gastritis; Pernicious anemia; Proton pump inhibitors; Reactive gastropathy

Indexed keywords

ANTIBIOTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADENOCARCINOMA; ATROPHY; BACTERIAL STRAIN; CARDITIS; CROHN DISEASE; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DUODENOGASTRIC REFLUX; DUODENUM ULCER; DYSPEPSIA; EOSINOPHILIC GASTRITIS; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; IMMUNITY; INTESTINE METAPLASIA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PEPTIC ULCER; PERNICIOUS ANEMIA; PRIORITY JOURNAL; RELIABILITY; REVIEW; RISK FACTOR; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH ULCER;

ADENOCARCINOMA; BIOPSY; DUODENAL ULCER; GASTRITIS; GASTROSCOPY; HELICOBACTER HEILMANNII; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MYOCARDITIS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0037394889     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000062995.72390.14     Document Type: Review

References (131)

1. Talley NJ, Hunt RH. What role does Helicobacter pylori play in dyspepsia and non-ulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology 1997;113(6 Suppl):S67-77.
2. Warren JR. Gastric pathology associated with Helicobacter pylori. Gastroenterol Clin North Am 2000;29:705-51.
3. Talley NJ, Janssens J, Lauritsen K. Eradication of Helicobacter pylori in functional dyspepsia: randomized double blind placebo controlled trial with 12 months' follow up. Br Med J 1999;318:833-57.
4. Elta GH, Appelman HD, Behier EM, et al. A study of the correlation between endoscopic and histologic diagnosis in gastroduodenitis. Am J Gastroenterol 1987;82:749-53.
5. Gad A. Erosion: a correlative endoscopic histological multicentric study. Endoscopy 1986;18:76-9.
6. Appelman H. Gastritis: terminology, etiology and clinicopathological correlations: another biased view. Hum Pathol 1994;25:1006-19.
7. Khakoo SI, Lobo AJ, Shepherd NA, Wilkinson SP. Histological assessment of the Sydney classification of endoscopic gastritis. Gut 1994;35:1172-5.
8. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 1995;108:917-24.
9. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
10. Whitehead R. The classification of chronic gastritis: current status. J Clin Gastroenterol 1995;21(Suppl 1):S131-4.
11. Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992;102:720-7.
12. Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM, et al. Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl 1997;223:28-34.
13. Genta RM. Helicobacter pylori, inflammation, mucosal damage and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology 1997;113(6 Suppl):S51-5.
14. Robert ME, Weinstein WM. Helicobacter pylori associated gastric pathology. Gastroenterol Clin North Am 1993;22:59-72.
15. Ruiz B, Garay J, Johnson E, et al. Morphometric assessment of gastric antral atrophy: comparison with visual evaluation. Histopathology 2001;39:235-42.
16. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19(Suppl 1):S37-43.
17. Vemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
18. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
19. Satob K. Does eradication of Helicobacter pylori reverse atrophic gastritis or intestinal metaplasia? Data from Japan. Gastroenterol Clin North Am 2000;29:829-35.
20. Genta RM. Atrophy, acid suppression and Helicobacter pylori infection: a tale of two studies. Eur J Gastroenterol Hepatol 1999;1:529-33.
21. Fiocca R, Luinetti O, Villani L, et al. Epithelial cytotoxicity, immune responses and inflammatory components of Helicobacter pylori gastritis. Scand J Gastroenterol 1994;205(Suppl):11-21.
22. Ernst PB, Crowe SE, Reyes VE. How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 1997;113(Suppl 6):S35-42.
23. Recentlon gastric mucosal damage, gastric cancer and MALT lymphoma. Gastroenterology 1997;113(Suppl 6):S65-6.
24. Axon AT. Are all helicobacters equal? Mechanisms of gastroduodenal pathology and their clinical implications. Gut 1999;45(Suppl):1-4.
25. Nogueira C, Figueiedo C, Carneiro F, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001;158:647-54.
26. Valle J, Kekki M, Sipponen, Ihamaki T, Siurala M. Long term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996;31:546-550.
27. Solcia E, Fiocca R, Villani L, Luinetti O, Capella C. Hyperplastic, dysplastic and neoplastic enterochromaffin-like cell proliferations of the gastric mucosa. Am J Surg Pathol 1995;19(Suppl):S1-7.
28. Kokkola A, Sjoblom SM, Haapiainen R, et al. The risk of gastric carcinoma and carcinoid tumors in patients with pernicious anemia. A prospective follow-up study. Scand J Gastroenterol 1998;33:88-92.
29. Ban-Hock T, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997;337:1441-8.
30. Negrini R, Savio A, Appelmelk BJ. Autoantibodies to gastric mucosa in Helicobacter pylori infection. Helicobacter 1997;2(Suppl 1):S13-6.
31. Faller G, Winter M, Steininger H, et al. Gastric autoantibodies and gastric secretary function in Helicobacter pylori-infected patients with duodenal ulcer and non-ulcer-dyspepsia. Scand J Gastroenterol 1998;33:276-82.
32. Faller G, Steininger H, Kranziein J, et al. Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 1997;41:619-23.
33. Faller G, Kirchner T. Role of gastric autoantibodies in chronic Helicobacter pylori infection. Microsc Res Tech 2000;15:321-6.
34. Claeys D, Faller G, Appelmelk BJ, Negrini R, Kirchner T. The gastric H+K+ ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosal atrophy. Gastroenterology 1998;115:340-7.
35. Stopeck A. Links between Helicobacter pylori infection, cobalamin deficiency and pernicious anemia. Arch Intern Med 2000;160:1229-30.
36. Kaptan K, Beyan C, Ural AU, et al. Helicobacter pylori - is it a novel causative agent of vitamin BI2 deficiency? Arch Intern Med 2000;160:1349-53.
37. Varis O, Valle J, Siurala M. Is Helicobacter pylori involved in the pathogenesis of the gastritis characteristic of pernicious anemia? Scand J Gastroenterol 1993;28:705-8.
38. Tepes B, Kavcic B, Zaletel LK, et al. Two-to-four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication. J Pathol 1999;188:24-9.
39. Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001;134:380-6.
40. Valle J, Seppala K, Sipponen P, Kosunen T. Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol 1991;26:1057-65.
41. Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 1993;6:281-9.
42. Sung JJ, Lin SR, Ching JY, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomised study. Gastroenterology 2000;119:7-14.
43. Forbes GM, Warren JR, Glaser ME, et al. Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 1996;11:670-3.
44. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995;90:1401-6.
45. Moayyedi P, Watson P, Peacock R, et al. Changing patterns of Helicobacter pylori gastritis in long standing acid suppression. Helicobacter 2000;5:206-14.
46. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety and influence on gastric mucosa. Gastroenterology 2000;118:661-9.
47. Lundell L, Miettinen P, Myrvold HE, et al. Lack of effect of acid suppression on gastric atrophy. Gastroenterology 1999;117:319-26.
48. Driman DK, Wright C, Tongas G, et al. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig Dis Sci 1996;41:2039-47.
49. Chondhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps. Am J Clin Pathol 1998;110:615-21.
50. Cats A, Schenk BE, Bloemena E, et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol 2000;31:684-90.
51. Krishnamurthy S, Dayal Y. Parietal cell protrusions in gastric ulcer disease. Hum Pathol 1997;28:1126-30.
52. Aprile MR, Azzoni C, Gibril F, Jensen RT, Bordi C. Intramucosal cysts in the body of patients with Zollinger-Ellison syndrome. Hum Pathol 2000;31:140-8.
53. Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol 2001;116:716-20.
54. McNulty CA, Dent JC, Curry A, et al. New spiral bacterium in gastric mucosa. J Clin Pathol 1989;42:585-91.
55. Oliva MM, Lazenby AJ, Perman JA. Gastritis associated with Gastrospirillum hominis in children. Comparison with Helicobacter pylori and review of the literature. Mod Pathol 1993;6:513-5.
56. Hilzenrat N, Lamoureux E, Weintraub I, et al. Helicobacter heilmannii-like spiral bacteria in gastric mucosal biopsies. Prevalence and clinical significance. Arch Pathol Lab Med 1995;119:1149-53.
57. Holck S, Ingeholm P, Blom J, et al. The histopathology of human gastric mucosa inhabited by Helicobacter heilmannii-like (Gastrospirillum hominis) organisms, including the first culturable case. APMIS 1997;105:746-56.
58. Svec A, Kordas P, Paviis Z, Novotny J. High prevalence of Helicobacter heilmannii-associated gastritis in a small predominately rural area: further evidence in support of a zoonosis? Scand J Gastroenterol 2000;35:925-8.
59. Yali Z, Yamada N, Won M, Matsuhisa T, Miki M. Gastrospirillum hominis and Helicobacter pylori infection in Thai individuals - comparison of histopathological changes of gastric mucosa. Pathol Int 1998;48:507-11.
60. Mazzucchelli L, Wilder-Smith CH, Ruchti C, Meyer-Wyss B, Merki HS. Gastrospirillum hominis in asymptomatic healthy individuals. Dig Dis Sci 1993;38:2087-9.
61. Meining A, Krohler G, Stolte M. Animal reservoirs in the transmission of Helicobacter heilmannii. Scand J Gastroenterol 1998;33:795-8.
62. Dixon MF, O'Connor HJ, Axon ATR, King RFJG, Johnson D. Reflux gastritis: distinct histopathology entity. J Clin Pathol 1986;39:524-30.
63. Ritchie WP Jr. Alkaline reflux gastritis. Gastroenterol Clin North Am 1994;23:281-94.
64. Burden WR, Hodges RP, Hsu M, O'Leary JP. Alkaline reflux gastritis. Surg Clin North Am 1991;71:33-44.
65. Sobala GM, King RFG, Axon ATR, Dixon MF. Reflux gastritis in the intact stomach. J Clin Pathol 1990;43:303-6.
66. Wilson P, Jamieson JR, Hindler RA, et al. Pathologic duodenogastric reflux associated with persistence of symptoms after cholecystectomy. Surgery 1995;117:421-8.
67. Haber MM, Lopez I. Reflux gastritis in gastroesophageal reflux disease: a histopathological study. Ann Diagn Pathol 1999;3:281-6.
68. Dixon MF, Neville PM, Mapstone NP, Moayyedi P, Axon AT. Bile reflux gastritis and Barrett's esophagus: further evidence of a role for duodenogastric-oesophageal reflux. Gut 2001;49:359-63.
69. McCarthy DM. Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory agents. Scand J Gastroenterol Suppl 1991;187:91-7.
70. McCarthy CJ, McDermott M, Hourihane D, O'Morain C. Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection. J Clin Pathol 1995;48:61-3.
71. Quinn CM, Bjarnason I, Price AB. Gastritis in patients on non-steroidal anti-inflammatory drugs. Histopathology 1993;23:341-8.
72. Laine L. Non-steroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin N Am 1996;6:489-504.
73. Voutilainen M, Sokka T, Juhola M, Farkkila M, Hannonen P. Non-steroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection and other risk factors for peptic ulcer. Scand J Gastroenterol 1998;33:811-6.
74. Haber MM, Lopez L. Gastric histologic findings in patients with non-steroidal anti-inflammatory drug-associated gastric ulcer. Mod Pathol 1999;12:592-8.
75. Frezza AA, Gorji N, Molato M. The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and hemorrhagic events. J Clin Pathol 2001;54:521-5.
76. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433-42.
77. El-Zimaity HM, Genta RM, Graham DY. Histological features do not define NSAID-induced gastropathy. Hum Pathol 1996;27:1348-54.
78. Dixon MF, O'Connor HJ, Axon AT, King RF, Johnston D. Reflux gastritis: distinct histopathological entity? J Clin Pathol 1986;39:524-30.
79. Haot J, Hamichi L, Waliez L, Mainguet P. Lymphocytic gastritis: a newly described entity: a retrospective endoscopic and histological study. Gut 1988;29:1258-64.
80. Haot J, Jouret A, Willette M, Gossuin A, Mainguet P. Lymphocytic gastritis - prospective study of its relationship with varioliform gastritis. Gut 1990;31:282-5.
81. Haot J, Bogomoletz WY, Jouret A, Mainguet P. Menetrier's disease with lymphocytic gastritis: an unusual association with possible pathogenetic implications. Hum Pathol 1991;22:379-86.
82. Wolber RA, Owen DA, Anderson FH, Freeman HJ. Lymphocytic gastritis and giant folds associated with gastrointestinal protein loss. Mod Pathol 1991;4:13-5.
83. Groisman GM, George J, Berman D, Harpaz N. Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1548-51.
84. Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology 1994;106:1310-9.
85. Dixon MF, Wyatt JL, Burke DA, Rathbone BJ. Lymphocytic gastritis - relationship to Campylobacter pylori infection. J Pathol 1988;154:125-32.
86. Jaskiewicz K, Price SK, Zak J, Louwrens HD. Lymphocytic gastritis in non-ulcer dyspepsia. Dig Dis Sci 1991;36:1079-83.
87. Wu TT, Hamilton SR. Lymphocytic gastritis: association with etiology and topology. Am J Surg Pathol 1999;23:153-8.
88. Niemela S, Karttunen T, Kerola T, Karttunen R. Ten year follow-up study of lymphocytic gastritis: further evidence on Helicobacter pylori as a cause of lymphocytic gastritis and corpus gastritis. J Clin Pathol 1995;48:1111-6.
89. Hayat M, Arora DS, Dixon MF, Clark B, O'Mahony S. Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut 1999;45:495-8.
90. Wolber RA, Owen D, DelBuono L, Appelman H, Freeman HJ. Lymphocytic gastritis in patients with celiac sprue or sprue like intestinal disease. Gastroenterology 1990;21:1092-6.
91. Jevon GP, Dimmick JE, Dohil R, Hassall EG. Spectrum of gastritis in celiac disease in childhood. Pediatr Dev Pathol 1999;2:221-6.
92. Feeley KM, Heneghan MA, Stephens FM, McCarthy CF. Lymphocytic gastritis and coeliac disease: a positive association. J Clin Pathol 1998;51:207-10.
93. Lynch DA, Sobala GM, Dixon MF, et al. Lymphocytic gastritis and associated small bowel disease: a diffuse lymphocytic gastroenteropathy. J Clin Pathol 1995;48:939-45.
94. Alsaigh N, Odze R, Goldman H, et al. Gastric and esophageal intraepithelial lymphocytes in pediatric celiac disease. Am J Surg Pathol 1996;20:865-70.
95. Hayat M, Arora DS, Wyatt JI, O'Mahony S, Dixon MF. The pattern of involvement of the gastric mucosa in lymphocytic gastritis is predictive of the presence of duodenal pathology. J Clin Pathol 1999;52:815-9.
96. Zukerberg LR, Ferry JA, Southern JF, Harris NL. Lymphoid infiltrates of the stomach. Evaluation of histologic criteria for the diagnosis of low-grade gastric lymphoma on endoscopic biopsy specimens. Am J Surg Pathol 1991;15:1014-6.
97. Isaacson PG. Recent developments in our understanding of gastric lymphoma. Am J Surg Pathol 1996;20(Suppl 1):51-7.
98. Foss HD, Schmitt-Graff A, Daum S, et al. Origin of primary gastric T-cell lymphoma from intraepithelial T lymphocytes: report of two cases. Histopathology 1999;34:9-15.
99. Barth TF, Leithauser F, Dohner H, et al. Primary gastric apoptosis-rich T-cell lymphoma co-expressing CD4, CDS and cytotoxic molecules. Virchows Arch 2000;436:357-64.
100. Bariol C, Field A, Vickers CR, Ward R. Regression of gastric T cell lymphoma with eradication of Helicobacter pylori. Gut 2001;42:269-71.
101. Oberhuber G, Puspok A, Oesterroicher C, et al. Focally enhanced gastritis - a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997;112:698-706.
102. Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn's disease. Am J Surg Pathol 1998;22:383-90.
103. Halme L, Karkkainen P, Rautelin H, Kosunen TU, Sipponen P. High frequency of helicobacter negative gastritis in patients with Crohn's disease. Gut 1996;38:379-83.
104. Tobin JM, Sinha B, Ramani P, Saleh AR, Murphy MS. Upper gastrointestinal mucosal disease in pediatric Crohn disease and ulcerative colitis. A blinded control study. J Pediatr Gastroenterol Nutr 2001;32:443-8.
105. Sasaki M, Okada K, Kayama S, et al. Ulcerative colitis complicated by gastroduodenal lesions. J Gastroenterol 1996;31:585-9.
106. Mitomi H, Atari E, Uesugi H, et al. Distinctive diffuse duodenitis associated with ulcerative colitis. Dig Dis Sci 1997;42:684-93.
107. Terashima S, Hoshino Y, Kanzaki N, Kogure M, Gotoh M. Ulcerative duodenitis accompanying ulcerative colitis. J Clin Gastroenterol 2001;32:172-5.
108. Johnstone JM, Morson BC. Eosinophilic gastro-enteritis. Histopathology 1978;2:349-61.
109. Pincus GS, Coolidge C, Little MD. Intestinal anisakiasis. First case report from North America. Am J Med 1975;59:114-20.
110. Goldman H, Projansky R. Allergic proctitis and gastroenteritis in children. Clinical and mucosal biopsy features in 53 cases. Am J Surg Pathol 1986;10:75-86.
111. Shapiro JL, Goldblum JR, Petras RE. A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an "idiopathic" granulomatous gastritis? Am J Surg Pathol 1996;20:462-70.
112. Kilgore SP, Ormsby AH, Gramlich TL, et al. The gastric cardia: fact or fiction? Am J Gastroenterol 2000;95:921-4.
113. Zhou H, Greco MA, Daum F, Kahn E. Origin of cardiac mucosa: ontogenic considerations. Pediatr Dev Pathol 2001;4:358-63.
114. Ormsby AH, Kilgore SP, Goldblum JR, et al. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventative strategies in Barrett's esophagus. Mod Pathol 2000;13:614-20.
115. Chandrosoma PT, Der R, Ma Y, Dalton P, Taira M. Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 2000;24:40-409.
116. Chandrosoma PT. Letter to editor. Am J Gastroenterol 2000;95:2384-5.
117. Morini S, Zullo A, Hassan C, et al. Gastric cardia inflammation: role of Hellcobacter pylori infection and symptoms of gastroesophageal reflux disease. Am J Gastroenterol 2001;96:2337-40.
118. Voutilainen M, Farkkila M, Mocklin JP, et al. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. Am J Gastroenterol 1999;94:3175-80.
119. Chen YY, Antonioli DA, Spechler SJ, et al. Gastroesophageal reflux disease versus Helicobacter pylori infection as the chief cause of carditis. Mod Pathol 1998;11:950-6.
120. Voutilainen M, Farkkila M, Juhola M, Mocklin JP, Sipponen P. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalence and associations with endoscopic erosive esophagitis and gastritis. Gut 1999;45:644-8.
121. Polkowski W, van Lanschoft JJ, ten Kate FJ, et al. Intestinal and pancreatic metaplasia at the esoghagogastric junction in patients with Barrett's esophagus. Am J Gastroenterol 2000;95:617-25.
122. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998;114:633-9.
123. Genta RM, Hiihorman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915-9.
124. Lembo T, Ippoliti AF, Ramers C, Weinstein WM. Inflammation of the gastro-esophageal junction (carditis) in patients with symptomatic gastro-esophageal reflux disease: a prospective study. Gut 1999;45:484-8.
125. el-Zimaity HM, Verghose UJ, Ramchatesingh J, Graham DY. The gastric cardia in gastro-esophageal disease. J Clin Pathol 2000;53:619-25.
126. Sharma P, Topalovski M, Mayo MS, Sampliner RE, Weston AP. Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia. Am J Gastroenterol 2000;95:3107-11.
127. Bowery DJ, Clark GW, Williams GT. Patterns of gastritis in patients with gastro-oesophageal reflux disease. Gut 1999;45:798-803.
128. Der R, Tsao-Wei DD, Demeester T, et al. Carditis: a manifestation of gastroesophageal reflux disease. Am J Surg Pathol 2001;25:245-52.
129. Goldstein NS, Karim R. Gastric cardia inflammation and intestinal metaplasia: association with reflux esophagitis and Helicobacter pylori. Mod Pathol 1999;12:1017-24.
130. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal cancer. N Engl J Med 1999;340:825-31.
131. Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999;117:218-28.